IDiyas

For the Inventor, By the Inventor

Pearl River, NY, United States of America

Ralph G Child

USPTO Granted Patents = 19

Average Co-Inventor Count = 3.5

ph-index = 8

Forward Citations = 108(Granted Patents)


Location History:

  • Rockland, NY (US) (1989)
  • Pearl River, NY (US) (1976 - 2001)

Company Filing History:

goldMedal19 out of 3,580 
 
American Cyanamid Company
 patents

Years Active: 1976-2001

Loading Chart...
19 patents (USPTO):Explore Patents
1. 6281365 - (Gem-heterocyclodimethanamine-n,n′)platinum complexes (2001-08-28),
2. 4900756 - (2,2-bis(aminomethyl)-1,3-propranediol-N,N')platinum complexes (1990-02-13),
3. 4880790 - (Gem-heterocyclodimethanamine-N,N')platinum complexes (1989-11-14),
4. 4866092 - Platinum complexes of amines with novel dibasic acids (1989-09-12),
5. 4847381 - 2-Phenyl-4-quinoline carboxylic acids (1989-07-11),
6. 4760157 - (2,2,-bis(aminomethyl)-1,3-propanediol-N,N')platinum complexes (1988-07-26),
7. 4716157 - Heterocyclic-1,2-diamine platinum complexes (1987-12-29),
8. 4703115 - Platinum complexes of diamino-dideoxy sugars and di- or tricarboxylic (1987-10-27),
9. 4696936 - 3,6-bis (substituted) acridine N-oxides and N,N-dioxides and methods of (1987-09-29),
10. 4675336 - Platinum complexes of amines with dibasic acids (1987-06-23),
11. 4665210 - Platinum complexes of aliphatic tricarboxylic acids (1987-05-12),
12. 4587331 - Platinum complexes of polyhydroxylated alkylamines and (1986-05-06),
13. 4419354 - 9,10-Bis(aminoalkoxy)anthracenes (1983-12-06),
14. 4235996 - Bis(2-imida (1980-11-25),
15. 4187373 - Novel dihydrobenzanthracene derivatives (1980-02-05),

Title: Innovations by Ralph G. Child in Anti-Cancer Research

Introduction

Ralph G. Child, based in Pearl River, NY, is an accomplished inventor with a significant contribution to the field of anti-cancer agents. With a total of 19 patents to his name, Child has made notable advancements that hold great promise for future medical applications. His work focuses on organic platinum complexes that show potential in the treatment of tumors.

Latest Patents

Among Child’s latest patents are groundbreaking compounds aimed at combatting cancer. The first is titled "(Gem-heterocyclodimethanamine-n,n′)platinum complexes," which describes organic platinum complexes recognized for their activity as anti-tumor agents in warm-blooded animals, along with methods for their synthesis. Another significant patent is for "(2,2-bis(aminomethyl)-1,3-propanediol-N,N')platinum complexes," which outlines organic platinum complexes that prove useful as anti-cancer agents specifically for tumors sensitive to these innovative compounds.

Career Highlights

Ralph G. Child has made substantial contributions to the field of cancer research through his affiliation with the American Cyanamid Company. His innovative chemistry has paved the way for novel therapeutic strategies in oncology. Child's patents reflect his commitment and ingenuity in a field that continues to evolve toward improved patient outcomes.

Collaborations

Throughout his career, Child has collaborated with other skilled researchers, including Yang-I Lin and Panayota Bitha. These partnerships have resulted in the development of innovative solutions and further advancements in the synthesis of anti-cancer agents.

Conclusion

Ralph G. Child stands out in the realm of cancer research with his prolific patent portfolio and significant contributions to the development of organic platinum complexes. His efforts are notable not only for their potential impact on cancer treatment but also for their embodiment of innovation within the pharmaceutical industry. As research continues to advance, Child's work remains a critical component in the fight against cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…